Clinical Trials Logo

Antirheumatic Agents clinical trials

View clinical trials related to Antirheumatic Agents.

Filter by:
  • None
  • Page 1

NCT ID: NCT04340349 Enrolling by invitation - Hydroxychloroquine Clinical Trials

Low-dose Hydroxychloroquine and Bromhexine: a Novel Regimen for COVID-19 Prophylaxis in Healthcare Professionals

ELEVATE
Start date: February 1, 2021
Phase: Early Phase 1
Study type: Interventional

This study will investigate the security and efficacy of a daily low dose of hydroxychloroquine and Bromhexine, in preventing the development of the disease from COVID-19 in Health Care Workers at a National Institute of Health In Mexico City.

NCT ID: NCT02648464 Completed - Clinical trials for Cardiovascular Diseases

Hydroxychloroquine for the Prevention of Cardiovascular Events in Myocardial Infarction Patients - a Safety Pilot Trial

OXI
Start date: February 1, 2016
Phase: Phase 4
Study type: Interventional

This safety pilot study evaluates the effect of hydroxychloroquine on preventing recurrent cardiovascular events among myocardial infarction patients. Half of the participants will receive hydroxychloroquine, whereas the other half will receive placebo during six months.